BiotechTube
Latitude Pharmaceuticals

Latitude Pharmaceuticals

San Diego, United States· Est.
latitudepharma.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Latitude Pharmaceuticals is a specialized, privately-held CRO/CMO focused on advanced formulation development and manufacturing. Its core value proposition lies in a suite of proprietary drug delivery platforms, most notably its ClearSol™ solubilizing vehicle, designed to overcome significant solubility and bioavailability hurdles for client compounds. With a track record of over 1,100 projects for more than 250 clients, the company has established a reputation for technical innovation and reliable service, operating as a critical partner for companies lacking in-house formulation expertise.

Drug DeliverySmall Molecules

Technology Platform

A portfolio of proprietary drug delivery and formulation platforms designed to overcome solubility, stability, and bioavailability challenges. Key platforms include ClearSol™ (aqueous solubilizer), Nano-E™ (nanoemulsion), PG Depot™ (injectable sustained-release gel), ARTSS (room-temperature stable solutions), RFAP (amorphous powders), and others for oral, topical, and veterinary delivery.

Opportunities

The persistent high prevalence of poorly soluble APIs in drug development pipelines creates a large, sustained demand for advanced formulation expertise.
The growth of the outsourcing CDMO market and the potential to license its proprietary platforms (like ClearSol™) offer significant revenue expansion avenues beyond traditional service fees.

Risk Factors

Revenue is tied to the R&D spending of biotech and pharma clients, making it vulnerable to sector funding downturns.
The company operates in a competitive CRO/CDMO landscape and must continuously innovate to protect its technological edge and intellectual property.

Competitive Landscape

Latitude competes within the formulation-focused segment of the broader CDMO market, against players like Catalent, Lubrizol Life Science, and numerous niche specialists. Its differentiation is its deep focus on solving extreme solubility challenges and its ownership of proprietary, clinically-validated platform technologies like ClearSol™.

More companies in Drug Delivery & Formulation →More companies in United States →